HEADER CHAPERONE 30-SEP-22 8B7I TITLE HUMAN HSP90 ALPHA ATP BINDING DOMAIN, ATP-LID OPEN CONFORMATION, R60A COMPND MOL_ID: 1; COMPND 2 MOLECULE: HSP90AA1 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28 KEYWDS CHAPERONE, HUMAN CHAPERONE PROTEIN, HSP90 ALPHA, N-TERMINAL DOMAIN, KEYWDS 2 ATP BINDING DOMAIN, GROUND STATE, ATP-LID OPEN STATE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR E.RIOUAL,F.HENOT,A.FAVIER,P.MACEK,E.CRUBLET,P.JOSSO,B.BRUTSCHER, AUTHOR 2 M.FRECH,P.GANS,C.LOISON,J.BOISBOUVIER REVDAT 3 19-JUN-24 8B7I 1 REMARK REVDAT 2 28-DEC-22 8B7I 1 JRNL REVDAT 1 16-NOV-22 8B7I 0 JRNL AUTH F.HENOT,E.RIOUAL,A.FAVIER,P.MACEK,E.CRUBLET,P.JOSSO, JRNL AUTH 2 B.BRUTSCHER,M.FRECH,P.GANS,C.LOISON,J.BOISBOUVIER JRNL TITL VISUALIZING THE TRANSIENTLY POPULATED CLOSED-STATE OF HUMAN JRNL TITL 2 HSP90 ATP BINDING DOMAIN. JRNL REF NAT COMMUN V. 13 7601 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36494347 JRNL DOI 10.1038/S41467-022-35399-8 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH F.HENOT,E.RIOUAL,A.FAVIER,P.MACEK,E.CRUBLET,P.JOSSO, REMARK 1 AUTH 2 B.BRUTSCHER,M.FRECH,P.GANS,C.LOISON,J.BOISBOUVIER REMARK 1 TITL VISUALIZING THE TRANSIENTLY POPULATED CLOSED-STATE OF HUMAN REMARK 1 TITL 2 HSP90 ATP BINDING DOMAIN REMARK 1 REF BIORXIV 2022 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2022.03.16.484593 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8B7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1292125481. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : 1 BAR REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-15N; U-2H; 13C(1H)3 REMARK 210 ALA-B, ILE-D1, LEU-D2, MET-E, REMARK 210 THR-G, VAL-G2] HSP90 ALPHA NTD, REMARK 210 150 MM NA+, 150 MM CL-, 1 MM REMARK 210 TCEP, 20 MM [U-2H] HEPES, 100% REMARK 210 D2O; 0.5 MM [U-2; U-15N; LEU U- REMARK 210 13C, U-2H, 13C(1H)3D2, 12C(2H) REMARK 210 3D1; VAL U-13C, U-2H, 13C(1H)3G2, REMARK 210 12C(2H)3G1; ILE U-13C, U-2H, REMARK 210 13C(1H)3D1, 12C(2H)3G2] HSP90 REMARK 210 ALPHA NTD, 150 MM NA+, 150 MM CL- REMARK 210 , 1 MM TCEP, 20 MM [U-2H] HEPES, REMARK 210 100% D2O; 0.5 MM [U-15N; THR U- REMARK 210 13C; ALA U-13C] HSP90 ALPHA NTD, REMARK 210 150 MM NA+, 150 MM CL-, 1 MM REMARK 210 TCEP, 20 MM HEPES, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-13C NOESY; 3D HCC-COSY; 2D REMARK 210 METHYL-TROSY; 3D HC(C)C-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 950 MHZ; 850 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.98.13, CCPNMR ANALYSIS REMARK 210 2.5.2 REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 MET A -29 REMARK 465 GLY A -28 REMARK 465 SER A -27 REMARK 465 SER A -26 REMARK 465 HIS A -25 REMARK 465 HIS A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 SER A -19 REMARK 465 SER A -18 REMARK 465 GLY A -17 REMARK 465 LEU A -16 REMARK 465 VAL A -15 REMARK 465 PRO A -14 REMARK 465 ARG A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 HIS A -10 REMARK 465 ASN A -9 REMARK 465 GLN A -8 REMARK 465 THR A -7 REMARK 465 SER A -6 REMARK 465 LEU A -5 REMARK 465 TYR A -4 REMARK 465 LYS A -3 REMARK 465 LYS A -2 REMARK 465 ALA A -1 REMARK 465 GLY A 0 REMARK 465 PHE A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 LEU A 4 REMARK 465 TYR A 5 REMARK 465 PHE A 6 REMARK 465 GLN A 7 REMARK 465 GLY A 8 REMARK 465 ASP A 9 REMARK 465 GLN A 10 REMARK 465 LYS A 224 REMARK 465 GLU A 225 REMARK 465 ARG A 226 REMARK 465 ASP A 227 REMARK 465 LYS A 228 REMARK 465 GLU A 229 REMARK 465 VAL A 230 REMARK 465 SER A 231 REMARK 465 ASP A 232 REMARK 465 ASP A 233 REMARK 465 GLU A 234 REMARK 465 ALA A 235 REMARK 465 GLU A 236 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HG1 THR A 99 OD1 ASP A 102 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 40 45.24 -88.63 REMARK 500 1 LEU A 107 -69.53 -136.93 REMARK 500 1 THR A 109 27.23 -140.82 REMARK 500 1 ALA A 166 -137.98 64.30 REMARK 500 2 ASN A 106 -31.41 75.42 REMARK 500 2 SER A 113 -52.52 74.31 REMARK 500 2 ALA A 166 -138.08 68.47 REMARK 500 2 PHE A 213 57.96 -97.09 REMARK 500 3 ASN A 106 75.63 -155.99 REMARK 500 3 LEU A 107 -56.53 -150.99 REMARK 500 3 THR A 109 27.37 -144.21 REMARK 500 3 ILE A 110 87.02 -67.76 REMARK 500 3 ALA A 111 5.90 -155.32 REMARK 500 3 THR A 115 -18.16 71.09 REMARK 500 3 ALA A 166 -138.71 64.57 REMARK 500 3 PHE A 213 59.59 -91.42 REMARK 500 4 ASN A 40 59.49 -91.90 REMARK 500 4 ALA A 111 95.48 -169.04 REMARK 500 4 LYS A 112 -49.14 -134.33 REMARK 500 4 ALA A 166 -126.98 66.06 REMARK 500 4 PHE A 213 47.54 -95.94 REMARK 500 5 MET A 12 -55.46 -134.19 REMARK 500 5 GLU A 13 107.23 66.14 REMARK 500 5 PHE A 138 -34.45 -132.59 REMARK 500 5 ALA A 166 -137.70 65.35 REMARK 500 5 ARG A 182 136.06 -172.99 REMARK 500 5 PHE A 213 51.41 -92.26 REMARK 500 6 ILE A 110 -85.97 -98.99 REMARK 500 6 ALA A 111 84.70 57.81 REMARK 500 6 LYS A 112 -84.37 -99.19 REMARK 500 6 ALA A 166 -137.51 65.57 REMARK 500 7 MET A 12 -56.02 -142.30 REMARK 500 7 GLU A 13 89.15 66.18 REMARK 500 7 LYS A 112 85.03 -163.19 REMARK 500 7 SER A 113 77.34 68.69 REMARK 500 7 ALA A 166 -134.44 69.52 REMARK 500 7 PHE A 213 50.99 -91.84 REMARK 500 8 GLU A 15 121.45 71.43 REMARK 500 8 ALA A 111 21.50 -148.99 REMARK 500 8 THR A 115 -3.45 71.36 REMARK 500 8 ALA A 166 -138.32 67.37 REMARK 500 8 PHE A 213 55.19 -92.63 REMARK 500 9 MET A 12 137.76 68.62 REMARK 500 9 ALA A 111 -30.61 -166.33 REMARK 500 9 SER A 113 -14.60 70.92 REMARK 500 9 ALA A 166 -136.74 66.61 REMARK 500 9 PHE A 213 59.11 -92.45 REMARK 500 10 MET A 12 95.63 66.85 REMARK 500 10 ASN A 40 56.47 -90.99 REMARK 500 10 LEU A 107 -52.64 -164.09 REMARK 500 REMARK 500 THIS ENTRY HAS 118 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34758 RELATED DB: BMRB REMARK 900 HSP90-NTD - R60A DBREF 8B7I A 9 236 UNP Q2VPJ6 Q2VPJ6_HUMAN 9 236 SEQADV 8B7I MET A -29 UNP Q2VPJ6 INITIATING METHIONINE SEQADV 8B7I GLY A -28 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I SER A -27 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I SER A -26 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -25 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -24 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -23 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -22 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -21 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -20 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I SER A -19 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I SER A -18 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLY A -17 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I LEU A -16 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I VAL A -15 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I PRO A -14 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I ARG A -13 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLY A -12 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I SER A -11 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I HIS A -10 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I ASN A -9 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLN A -8 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I THR A -7 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I SER A -6 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I LEU A -5 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I TYR A -4 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I LYS A -3 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I LYS A -2 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I ALA A -1 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLY A 0 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I PHE A 1 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLU A 2 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I ASN A 3 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I LEU A 4 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I TYR A 5 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I PHE A 6 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLN A 7 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I GLY A 8 UNP Q2VPJ6 EXPRESSION TAG SEQADV 8B7I THR A 63 UNP Q2VPJ6 SER 63 CONFLICT SEQRES 1 A 266 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 266 LEU VAL PRO ARG GLY SER HIS ASN GLN THR SER LEU TYR SEQRES 3 A 266 LYS LYS ALA GLY PHE GLU ASN LEU TYR PHE GLN GLY ASP SEQRES 4 A 266 GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE ALA PHE SEQRES 5 A 266 GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE ILE ASN SEQRES 6 A 266 THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG GLU LEU SEQRES 7 A 266 ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE ARG TYR SEQRES 8 A 266 GLU THR LEU THR ASP PRO SER LYS LEU ASP SER GLY LYS SEQRES 9 A 266 GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN ASP ARG SEQRES 10 A 266 THR LEU THR ILE VAL ASP THR GLY ILE GLY MET THR LYS SEQRES 11 A 266 ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA LYS SER SEQRES 12 A 266 GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA GLY ALA SEQRES 13 A 266 ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY PHE TYR SEQRES 14 A 266 SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL ILE THR SEQRES 15 A 266 LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SER SER SEQRES 16 A 266 ALA GLY GLY SER PHE THR VAL ARG THR ASP THR GLY GLU SEQRES 17 A 266 PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS LEU LYS SEQRES 18 A 266 GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG ILE LYS SEQRES 19 A 266 GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY TYR PRO SEQRES 20 A 266 ILE THR LEU PHE VAL GLU LYS GLU ARG ASP LYS GLU VAL SEQRES 21 A 266 SER ASP ASP GLU ALA GLU HELIX 1 AA1 GLN A 23 THR A 36 1 14 HELIX 2 AA2 GLU A 42 ASP A 66 1 25 HELIX 3 AA3 PRO A 67 ASP A 71 5 5 HELIX 4 AA4 THR A 99 LEU A 107 1 9 HELIX 5 AA5 GLY A 114 ALA A 124 1 11 HELIX 6 AA6 ASP A 127 GLY A 132 1 6 HELIX 7 AA7 GLN A 133 GLY A 135 5 3 HELIX 8 AA8 VAL A 136 LEU A 143 5 8 HELIX 9 AA9 GLU A 192 LEU A 198 5 7 HELIX 10 AB1 GLU A 199 SER A 211 1 13 SHEET 1 AA1 8 GLU A 18 ALA A 21 0 SHEET 2 AA1 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 AA1 8 GLN A 159 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 AA1 8 ALA A 145 LYS A 153 -1 N THR A 152 O TYR A 160 SHEET 5 AA1 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 AA1 8 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186 SHEET 7 AA1 8 ILE A 78 ASN A 83 -1 N ILE A 81 O THR A 90 SHEET 8 AA1 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1